| 中文名称： | VX-740 |
| smiles： | CCO[C@@H]1OC(=O)C[C@@H]1NC([C@@H]1CCCN2C(CC[C@@H](C(=O)N12)NC(C1=NC=CC2=CC=CC=C12)=O)=O)=O |
| 英文名称： | Pralnacasan |
| 英文别名： | 6H-Pyridazino[1,2-a][1,2]diazepine-1-carboxamide,N-[(2R,3S)-2-ethoxytetrahydro-5-oxo-3-furanyl]octahydro-9-[(1-isoquinolinylcarbonyl)amino]-6,10-dioxo-,(1S,9S)-;(4S,7S)-N-[(2R,3S)-2-ethoxy-5-oxooxolan-3-yl]-7-(isoquinoline-1-carbonylamino)-6,10-dioxo-2,3,4,7,8,9-hexahydro-1H-pyridazino[1,2-a]diazepine-4-carboxamide;6H-Pyridazino[1,2-a][1,2]diazepine-1-carboxamide,N-[(2R,3S)-2-ethoxytetrahydro-5-oxo-3-furanyl...;6H-Pyridazino[1,2-a][1,2]diazepine-1-carboxamide,N-[(2R,3S)-2-ethoxytetrahydro-5-oxo-3-furanyl]octahydro-9-[(1-isoquinolinylc;AC1L4A1A;CHEBI:454956;CHEMBL437526;HMR 3480;Pralnaan;Pralnaan [INN];SureCN142187;UNII-N986NI319S;(3S,11S)-N-[(2R,3S)-2-ethoxy-5-oxo-oxolan-3-yl]-3-(isoquinoline-1-carbonylamino)-2,6-dioxo-1,7-diazabicyclo[5.4.0]undecane-11-carboxamide;(1S,9S)-N-[(2R,3S)-2-Ethoxy-5-oxotetrahydro-3-furanyl]-9-[(1-isoquinolinylcarbonyl)amino]-6,10-dioxooctahydro-6H-pyridazino[1,2-a][1,2]diazepine-1-carboxamide;Pralnacasan;192755-52-5;HMR-3480/VX-740;PRALNACASAN [USAN];VX740;N986NI319S;GTPL6467;VX-740;HMR 3480;D08978;VX 470;HMR3480;Pralnacasan [INN];VX-740;(1S,9S)-N-[(2R,3S)-2-ethoxy-5-oxooxolan-3-yl]-9-(isoquinoline-1-carbonylamino)-6,10-dioxo-2,3,4,7,8,9-hexahydro-1H-pyridazino[1,2-a]diazepine-1-carboxamide;AKOS030230853;CS-0016191;DB04875;HMR-3480;(3S,11S)-N-[(2R,3S)-2-ETHOXY-5-OXO-OXOLAN-3-YL]-3-(ISOQUINOLINE-1-CARBONYLAMINO)-2,6-DIOXO-1,7-DIAZABICYCLO[5.4.0]UNDECANE-11-CARBOXAMIDE;(1S,10S)-9-[(Isoquinoline-1-carbonyl)-amino]-6,10-dioxo-octahydro-pyridazino[1,2-a][1,2]diazepine-1-carboxylic acid ((S)-2-ethoxy-5-oxo-tetrahydro-furan-3-yl)-amide;Q27088439;BDBM50189360;SCHEMBL142187;Pralnacasan (USAN/INN);6H-Pyridazino(1,2-a)(1,2)diazepine-1-carboxamide, N-((2R,3S)-2-ethoxytetrahydro-5-oxo-3-furanyl)octahydro-9-((1-isoquinolinylcarbonyl)amino)-6,10-dioxo-, (1S,9S)-;DTXSID60172873;HY-19676;MS-29694;HMR3480/VX-740;Pralnacasan [USAN:INN];(1S,9S)-N-((2R,3S)-2-Ethoxy-5-oxotetrahydrofuran-3-yl)-9-((isoquinolin-1-ylcarbonyl)amino)-6,10-dioxooctahydro-6-H-pyridazino(1,2-a)(1,2)diazepine-1-carboxamide;(1S,9S)-N-((2R,3S)-2-Ethoxy-5-oxotetrahydrofuran-3-yl)-9-(isoquinoline-1-carboxamido)-6,10-dioxooctahydro-6H-pyridazino[1,2-a][1,2]diazepine-1-carboxamide;NS00069746;(1S,9S)-N-((2R,3S)-2-ethoxy-5-oxo-tetrahydrofuran-3-yl)-9-(isoquinoline-1-carboxamido)-6,10-dioxo-octahydro-1H-pyridazino[1,2-a][1,2]diazepine-1-carboxamide |
| CAS号： | 192755-52-5 |
| 分子式： | C26H29N5O7 |
| 分子量： | 523.54 |
| 密度： | |
| 熔点： | |
| 沸点： | |
| 闪点： | |
| 水溶性： | |
| 蒸气压： |
VX-740
英文名：
Pralnacasan
别名：
商品编号：R154352-1mg
规格：1mg
纯度：≥98%
CAS号： 192755-52-5
分子式：C26H29N5O7
分子量：523.54
| 价格 |
¥ 4610.00
（请 登录 会员查看折扣价）
|
| 货期 | 5~7个工作日 |
数量
搜索质检报告(COA)
搜索MSDS
相关产品
¥ 4610.00
¥ 4610.00
¥ 4610.00
¥ 4610.00
¥ 4610.00
¥ 4610.00
¥ 4610.00
¥ 4610.00
¥ 4610.00
¥ 4610.00
